GILEAD SCIENCES, INC.

Trading Ideas Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 12/12/2025 GMT			5-day change	1st Jan Change
120.40 ^USD	-2.28%		-0.68%	+30.35%

12-12	Arcus Biosciences, Inc. Provides Update on Phase 3 Star-221 Study and Concentrates Its R&D Investment on Cas Datifan and Emerging Inflammation and Immunology Portfolio	CI
12-12	Arcus, Gilead to Discontinue Phase 3 Trial of Potential Cancer Treatment -- Update	DJ

Trading Ideas

GILEAD SCIENCES, INC.: The underlying trend is in force again	11-12
GILEAD SCIENCES, INC.: The underlying trend is in force again	09-12
GILEAD SCIENCES, INC.: A medium term support level to take advantage of	07/10/20
GILEAD SCIENCES, INC.: Volatility should make a big comeback	03/02/20
GILEAD SCIENCES, INC.: A valuable trading opportunity	29/12/14
GILEAD SCIENCES, INC.: Continuation of the bullish trend	27/08/14
GILEAD SCIENCES, INC.: A "V bottom" takes shape	27/05/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Time To Grow PFL Fanbase, Revenue: CEO John Martin

Time To Grow PFL Fanbase, Revenue: CEO John Martin

July 11, 2025 at 09:09 am

The best tools reserved for subscribers to boost the performance of your investments!